Bioaffinity Technologies, Inc. (BIAF) - Form 8-K Summary
Business Context and Reporting Period
Bioaffinity Technologies, Inc., a Delaware corporation, filed this Current Report on Form 8-K on March 5, 2024. The filing serves to announce the issuance of a press release containing financial information for the fiscal year ended December 31, 2023. The company is designated as an emerging growth company and trades on The Nasdaq Stock Market LLC under the symbols BIAF (Common Stock) and BIAFW (Warrants).
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the financial data for the year ended December 31, 2023, is contained within the attached press release (Exhibit 99.1) rather than the body of this Form 8-K.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in this document. The filing acts solely as a notification of the release of the annual financial results.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and the attached press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, nor will it be incorporated by reference into any other SEC filings. No specific guidance, outlook, or risk factors are enumerated in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 5, 2024) for the actual financial figures for the year ended December 31, 2023.
- Verify the company's status as an emerging growth company and its implications for financial reporting.
- Confirm the trading status of Common Stock (BIAF) and Warrants (BIAFW) on The Nasdaq Stock Market LLC.
- Note that the financial data in the press release is not incorporated by reference into future SEC filings.